Research into cancer genomics is advancing our understanding of cancer development and progression, including the identification of cancer driver events.
To discover the breakthrough, you must be ready to handle the most urgent challenges:
- Uncovering cryptic tumor heterogeneity
- Extracting data from limited or challenging samples, such as formalin-fixed paraffin-embedded (FFPE) tissue or cell-free DNA (cfDNA) samples
- Analyzing and extracting key insights from vast amounts of data generated by multiple technologies
- Choosing the right technology for each stage of biomarker discovery and verification.
Thermo Fisher Scientific offers a variety of cancer genomics research solutions for comprehensive sample profiling, biomarker discovery and verification, and data analysis.
With access to these innovative products and platforms, you can uncover the genetic variants and RNA signatures you need to power your next breakthrough.
Accelerate your cancer research with our Oncomine assays and Ion AmpliSeq technology and panels.
The Oncomine cfTNA solutions combined with TaqMan Digital PCR Liquid Biopsy assays, offer a comprehensive set of tools for liquid biopsy applications, and in the future may enable noninvasive techniques towards personalized medicine.
Accurately screen or confirm somatic and germline variants of choice using sequencing and real-time PCR.
For Research Use Only. Not for use in diagnostic procedures.